文献速递外周动脉疾病

美国老年医保人群中慢性肢体威胁性缺血疾病负担的更新估计

Updated estimates for the burden of chronic limb-threatening ischemia in the Medicare population.
PubMed 文献 · J Vasc Surg · 2023-02-08

利用2017至2018年联邦医疗保险数据,以ICD-10-CM诊断码识别慢性肢体威胁性缺血(CLTI)患者,1年发病率为0.33%、2年患病率为0.74%,每100人年接受43.6次血管手术,1年生存率77.7%显著低于按年龄、性别和种族调整的预期生存率95.1%(P<.001)。

要点

  • 2017至2018年联邦医疗保险中CLTI的1年发病率为0.33%,2年患病率为0.74%。
  • CLTI患者平均每100人年接受43.6次血管手术,1年生存率77.7%,显著低于调整后预期生存率95.1%。
  • 男性较女性死亡风险显著升高(HR 1.07,95%CI 1.04-1.10,P<.001),种族与总生存无显著关联(HR 0.99,95%CI 0.98-1.01,P=.83)。

核心结论

  • 使用ICD-10-CM诊断码显示的CLTI发病率和患病率略高于已发表文献,反映本方法更完整。
  • 敏感性分析提示高度特异的ICD-10-CM编码复杂性可能降低CLTI的捕获。
  • 纳入非CLTI外周动脉疾病诊断患者可中度增加发病率和患病率,但降低识别CLTI患者的特异性。
  • 联邦医疗保险CLTI患者的中期观察生存率显著低于精算估计,确认需重点识别并对齐这一复杂人群的照护目标。

研究设计与样本

  • 利用联邦医疗保险与医疗补助服务中心2017至2018年两年数据,识别至少有一个CLTI诊断码的患者以确定患病率和发病率。
  • 进行敏感性分析,比较本方法与既往发表文献并量化漏诊程度。
  • 统计诊断后发生的血管手术数量和类型。
  • 识别有两个或以上CLTI诊断码的患者队列进行进一步描述性分析。
  • 使用Cox比例风险模型分析患者人口学特征与生存之间的关联。

主要发现

  • 患者平均每100人年接受43.6次血管手术。
  • 敏感性分析识别出额外89,805例有外周动脉疾病诊断码并接受血运重建或截肢的患者。
  • CLTI患者以男性(56.2%)、白人(76.4%)为主,64.0%因年龄符合联邦医疗保险资格,37%为双重资格。
  • 1年生存率为77.7%,显著低于按年龄、性别和种族调整的精算生存估计95.1%(P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 敏感性分析提示高度特异的ICD-10-CM编码复杂性可能降低CLTI的捕获。
  • 纳入非CLTI外周动脉疾病诊断患者可中度增加发病率和患病率,但降低识别CLTI患者的特异性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Estimates of chronic limb-threatening ischemia (CLTI) based on diagnosis codes of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) suggest a prevalence of 0.23%-0.32% and incidence of 0.20%-0.26% among Medicare patients. ICD-10-CM includes 144 CLTI diagnosis codes, allowing improved specificity in identifying affected patients. We sought to use ICD-10-CM diagnosis codes to determine the prevalence of CLTI among Medicare patients and describe the patient cohort affected by this condition. METHODS: Using two years of data from Centers for Medicare and Medicaid Services, we identified all patients that had at least one CLTI diagnosis code to determine prevalence and incidence rates. Sensitivity analyses were performed to compare our methodology to prior publications and quantify the extent of missed diagnoses. The number and type of vascular procedures that occurred after diagnosis were tabulated. A cohort of patients with two or more CLTI diagnosis codes were then identified for further descriptive analysis. Associations between patient demographics and survival were analyzed using Cox proportional hazards models. RESULTS: Over 65 million patients were enrolled in Medicare in 2017 to 2018. Of these, 480,227 had diagnosis of CLTI, with a corresponding to a 1-year incidence of 0.33% and a 2-year prevalence of 0.74%. Patients underwent an average of 43.6 vascular procedures per 100 person-years. Sensitivity analyses identified 89,805 additional patients that had a diagnosis code of peripheral arterial disease who underwent revascularization or amputation. Patients with CLTI were predominantly male (56.2%), white (76.4%), and qualified for Medicare due to age (64.0%). Thirty-seven percent were dual-eligible. One-year survival was 77.7%, significantly lower than estimated actuarial survival adjusted for age, sex, and race (95.1%; P < .001). Cox proportional hazards models demonstrate significantly increased mortality for men vs women (hazard ratio, 1.07; 95% confidence interval, 1.04-1.10; P < .001), but no association between race and overall survival (hazard ratio, 0.99; 95% confidence interval, 0.98-1.01; P = .83). CONCLUSIONS: Using ICD-10-CM diagnosis codes, we demonstrated slightly higher incidence and prevalence of CLTI than in published literature, reflecting our more complete methodology. Sensitivity analyses suggest that increased complexity of the highly specific ICD-10-CM coding may diminish capture of CLTI. Inclusion of patients with non-CLTI peripheral arterial disease diagnoses produces moderate increases in incidence and prevalence at the cost of decreased specificity in identifying patients with CLTI. Medicare patients with CLTI are older, and more commonly male, black, and dual eligible compared with the general Medicare population. Observed mid-term survival for patients with CLTI is significantly lower than actuarial estimates, confirming the importance of focused efforts on identifying and aligning goals of care in this complex patient population.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kwong M, Rajasekar G, Utter GH, et al. Updated estimates for the burden of chronic limb-threatening ischemia in the Medicare population. J Vasc Surg. 2023. PMID: 36758910. doi:10.1016/j.jvs.2023.01.200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。